Arcus Biosciences RCUS Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcus Biosciences's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcus Biosciences's total current liabilities?
- Arcus Biosciences (RCUS) reported total current liabilities of $209M in Q1 2026.
- How has Arcus Biosciences's total current liabilities changed year-over-year?
- Arcus Biosciences's total current liabilities increased by 8.9% year-over-year, from $192M to $209M.
- What is the long-term trend for Arcus Biosciences's total current liabilities?
- Over 5 years (2020 to 2025), Arcus Biosciences's total current liabilities has grown at a 13.7% compound annual growth rate (CAGR), from $121.67M to $231M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.